Condition
Depression, Unipolar
ClinicalTrials.gov condition label
Clinical trials
48 shownMaternal Mindfulness: Depression and Postpartum PainNCT05400382 · 2025-12-01
RECRUITINGAdjunctive Bright Light Therapy in Adolescents With Depression and EveningnessNCT06973759 · 2025-11-01
RECRUITINGNatural History of Depression, Bipolar Disorder and Suicide RiskNCT06462196 · 2024-09-09
RECRUITINGThe Cerebral and Cognitive Changes After Intermittent Theta Burst Stimulation (iTBS) Treatment for DepressionNCT06534684 · 2024-02-12
RECRUITINGBioClock: Bright Light Therapy for Depressive DisordersNCT05958940 · 2024-02-08
RECRUITINGIntermittent Theta-burst Stimulation for Major Depression: an Intensity-response StudyNCT06392867 · 2024-01-08
RECRUITINGEffects of CBT and BLT in Youth With Unipolar Depression and Evening ChronotypeNCT06092411 · 2023-10-31
RECRUITINGFMRI-neurofeedback in DepressionNCT05640089 · 2023-01-25
RECRUITINGIntegrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With DepressionNCT05011864 · 2021-11-01
RECRUITINGEfficacy of a Personalized, Response-based Transdiagnostic Intervention for Emotional Disorders Delivered Via the Internet: A Protocol for an Adaptive Randomized Controlled TrialNCT07051148 · 2027-05-01
NOT_YET_RECRUITINGDevelopment and Evaluation of a Digital Aftercare Program for Adolescents (12-17 Years) With Depressive Symptoms After Hospital Discharge (Mind-WIN Pilot Study) (Mind-WIN Pilot)NCT07007247 · 2025-05-13
ENROLLING_BY_INVITATIONRepeated Neurocognitive Measurements in Depressed PatientsNCT05991232 · 2025-05-01
WITHDRAWNPsychotherapy Feasibility Pilot of the Carolina Recovery From Depression ProtocolNCT06590038 · 2025-03-03
COMPLETEDPilot Study: Investigating Mood Changes After Slow-wave EnhancementNCT05146427 · 2025-01-01
WITHDRAWNCRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among LatinosNCT06139159 · 2023-11-10
ACTIVE_NOT_RECRUITINGSafety, Tolerability and Antidepressant Effects of DMT in Patients With DepressionNCT06094907 · 2023-10-09
COMPLETEDLifestyle InterVEntion Study in General Practice: LIVES - GPNCT06286345 · 2023-08-01
UNKNOWNPsychiatric Orders in Psychoanalytic Treatment of ASDNCT05930912 · 2023-06-01
UNKNOWNKetamine + Mindfulness for DepressionNCT05168735 · 2022-02-01
COMPLETEDAcceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate StudentsNCT05114824 · 2021-09-23
UNKNOWNRepeated Neurocognitive Measurements in Depressed PatientsNCT04916548 · 2021-09-16
COMPLETEDIM Ketamine vs Midazolam for Suicidal ER PatientsNCT04640636 · 2021-02-09
SUSPENDEDLIVES: Personalized Lifestyle Intervention for Patients With DepressionNCT05767073 · 2020-09-01
UNKNOWNSMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research ProjectNCT03466346 · 2020-08-31
COMPLETEDThe Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)NCT04399070 · 2020-08-01
UNKNOWNValidity and Reliability of Vietnamese Version of 17items-Hamilton Depression Rating ScaleNCT04205747 · 2020-01-01
UNKNOWNPramipexole to Target "Anhedonic Depression"NCT04121091 · 2019-10-04
COMPLETEDWhole-body Hyperthermia for Moderate to Severe Depressive DisorderNCT03906149 · 2019-07-01
COMPLETEDWhole-body Hyperthermia for Mild to Moderate Depressive DisorderNCT03906175 · 2019-06-11
COMPLETEDTracking Depression Symptoms With a Health ChatbotNCT03990389 · 2019-02-20
COMPLETEDPsychotherapeutic Augmentation of Brain Stimulation EffectsNCT04159285 · 2019-01-05
COMPLETEDMachine Learning to Predict Clinical Response to TMSNCT03847688 · 2018-10-22
UNKNOWNA Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on DepressionNCT03623711 · 2018-08-01
UNKNOWNPF-04995274 and Emotional Processing in Treatment Resistant DepressionNCT03515733 · 2018-05-31
COMPLETEDPF-04995274 and Emotional Processing in Un-medicated DepressionNCT03516604 · 2018-05-16
COMPLETEDCombinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive DisorderNCT03537547 · 2018-05-04
TERMINATEDChronobiology and Depression: Circadian Analytics as a Biomarker for Depressive SubtypesNCT03538275 · 2018-03-13
COMPLETEDSleep, Wake and Light Therapy for DepressionNCT03405493 · 2018-01-18
COMPLETEDReaching and Engaging Depressed Senior Center Clients (REDS)NCT03246789 · 2018-01-01
COMPLETEDPattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of VortioxetineNCT02969876 · 2017-08-24
TERMINATEDNovel Neural Circuit Biomarkers of Major Depression Response to CCBTNCT03096886 · 2017-06-05
COMPLETEDTrans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic DisorderNCT02954731 · 2016-12-01
COMPLETEDGaze Contingent Feedback in Major Depressive Disorder (MDD)NCT02945735 · 2016-11-06
COMPLETEDPulsed Electro Magnetic Fields (PEMF) in DepressionNCT03556735 · 2016-09-01
COMPLETEDExercise for DepressionNCT02874833 · 2016-07-01
COMPLETEDNeural Mechanisms Underlying the Antidepressant Effects of Sleep DeprivationNCT03169543 · 2016-04-01
COMPLETEDLow-Dose Naltrexone (LDN) for Depression Relapse and RecurrenceNCT01874951 · 2013-06-01
COMPLETEDTreating Major Depression With Yoga: A Prospective, Randomized Controlled Pilot TrialNCT01210651 · 2010-05-01
COMPLETEDCommon interventions
Intravenous KetamineDRUG3Bright Light TherapyDEVICE2PF-04995274DRUG2Placebo Oral TabletDRUG2Academic ExercisesBEHAVIORAL1Attention Control Education GroupBEHAVIORAL1Attention ModificationBEHAVIORAL1Auxiliary to careOTHER1Behavioral ActivationBEHAVIORAL1Blue Light Blocking GlassesDEVICE1Brief Mindfulness ExercisesBEHAVIORAL1Bright Light TherapyPROCEDURE1BupropionDRUG1Chatbot InterventionDEVICE1CitalopramDRUG1Cognitive Behavioral TherapyBEHAVIORAL1Cognitive Behavioural Therapy for DepressionBEHAVIORAL1Computer-Augmented Cognitive Behavioral TherapyBEHAVIORAL1Dim red lightDEVICE1DuloxetineDRUG1Duloxetine 20 MGDRUG1EffEKTiv 2.0 group CBT as continuation treatment after ECT in depressed patientsBEHAVIORAL1Engage-MBEHAVIORAL1EscitalopramDRUG1ExerciseOTHER1
Leading sponsors
University of Pennsylvania3Massachusetts General Hospital2Rebecca Price2Universität Duisburg-Essen2University Medical Center Groningen2University of California, San Francisco2University of Oxford2Brown University1Charite University, Berlin, Germany1Chinese University of Hong Kong1Drexel University1Jay Fournier1Johannes Gutenberg University Mainz1King's College London1Maastricht University Medical Center1
Trial status mix
COMPLETED23
RECRUITING9
UNKNOWN8
TERMINATED2
WITHDRAWN2
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1
SUSPENDED1
Phase mix
NA31
PHASE26
PHASE15
PHASE43
EARLY_PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.